Treatment of glioblastoma with thymosin-alpha 1

Details for Australian Patent Application No. 2002357115 (hide)

Owner Rhode Island Hospital

Inventors Wands, Jack R; De La Monte, Suzanne

Agent Wrays

Pub. Number AU-B-2002357115

PCT Number PCT/US02/39329

PCT Pub. Number WO2003/049697

Priority 60/337,149 10.12.01 US

Filing date 10 December 2002

Wipo publication date 23 June 2003

Acceptance publication date 13 December 2007

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 31/17 (2006.01) - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61K 31/175 (2006.01)

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

27 March 2003 Complete Application Filed

  Priority application(s): 60/337,149 10.12.01 US

28 August 2003 Application Open to Public Inspection

  Published as AU-B-2002357115

13 December 2007 Application Accepted

  Published as AU-B-2002357115

10 April 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002357116-ORAL APPLIANCE

2002357114-Treatment of neoplasia